Table 1.
Period | Jan 2008 – Oct 2012 | Oct 2012 – Dec 2017 | Total | |||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Age | ||||||
Mean | 64.5 | 65.2 | 64.9 | |||
Minimum | 18 | 17 | 17 | |||
Maximum | 99 | 100 | 100 | |||
Sex | ||||||
Female | 677 | 34 | 824 | 31 | 1501 | 32 |
Male | 1308 | 66 | 1840 | 69 | 3148 | 68 |
Total | 1985 | 100 | 2664 | 100 | 4649 | 100 |
Causative microorganism | ||||||
VGS | 497 | 25 | 653 | 25 | 1150 | 25 |
S. aureus | 728 | 37 | 995 | 37 | 1723 | 37 |
Other | 623 | 31 | 822 | 31 | 1445 | 31 |
Unknown | 137 | 7 | 194 | 7 | 331 | 7 |
Total | 1985 | 100 | 2664 | 100 | 4649 | 100 |
Mortality during treatment of IE | ||||||
VGS | 28 | 6 | 38 | 6 | 66 | 6 |
S. aureus | 115 | 16 | 113 | 13 | 248 | 14 |
Other | 58 | 9 | 79 | 10 | 137 | 9 |
Unknown | 8 | 6 | 15 | 8 | 23 | 7 |
Total | 209 | 11 | 265 | 10 | 474 | 10 |
The table shows the in-hospital mortality of IE caused by viridans group streptococci (VGS), Staphylococcus aureus, and other microorganisms (mainly enterococci and coagulase-negative staphylococci). Data are displayed separately for the period before and after the cessation of antibiotics in dentistry for the prevention of IE, in October 2012.